The U.S. Food and Drug and Administration (FDA) approved venetoclax to treat patients with chronic lymphocytic leukemia (CLL) with 17p deletion who have had at least one prior therapy. 17p deletion is a genetic mutation that can be detected by certain FDA approved tests.

Brain tumors are often treated with radiation. According to one study, the addition of chemotherapy to the treatment plan of brain cancer patients with slow-growing tumors may add years to the lives of patients. The study included 251 participants with grade 2 gliomas.

According to a new study of breast cancer survivors under 40, the rate of young women with breast cancer who receive BRCA mutation testing is increasing. About 77% of women diagnosed in 2006 underwent testing.

According to researchers at the Yale School of Public Health, the smoking habits of African Americans differ from those of white Americans. Even though African Americans appear to keep smoking longer, they smoke fewer cigarettes a day.

The U.S. Food and Drug Administration (FDA) approved obinutuzumab in combination with bendamustine followed by treatment with obinutuzumab alone as a second line treatment for patients with follicular lymphoma.

The U.S. Food and Drug Administration (FDA) recently issued a press release regarding cervical cancer. According to the FDA, cervical cancer is largely preventable thanks to three FDA-approved vaccines that protect against the disease.